Nutraceutical Demand Ceapro’s core products, oat beta glucan and avenanthramides, have established health and heart health claims and are expanding into nutraceutical applications, creating cross-selling opportunities with supplement brands and functional foods.

Cosmetic Ingredient Export Proprietary oat extraction processes and bioactive ingredients are already used by leading personal care brands, suggesting partnership potential with cosmetics manufacturers seeking natural, clinically supported actives and novel bio-nanocomposites.

Bioactive Delivery Ceapro’s PGX technology and plant-extraction manufacturing capabilities position the company to supply advanced delivery systems and high-value biopolymers to biotech and pharma players pursuing innovative drug-delivery solutions.

Strategic Merger Upside Following the Aeterna Zentaris merger, there is a broader biopharmaceutical platform and potential cross-sell of R&D services, licensing opportunities, and collaborative programs with larger science-focused organizations.

Global Health Claims Oat beta glucan and avenanthramides carry multi-region health claims (Canada, US, Europe), enabling targeted selling to regulatory-compliant brands seeking evidence-backed ingredients for heart health, inflammation control, and skincare therapeutics.